bpc-157 safety regulatory status fda BPC 157 Banned: Key Facts on the Latest Decision bpc-157 safety regulatory status fda
Description
One user with 15-year patellar tendonitis reported dramatic initial improvement in the first two weeks, but then the progress drastically slowed despite experimenting with different doses and injection sites
Think of it like this: a doctor needs an X-ray to confirm a broken bone before putting on a cast
All evidence is preclinical in mice only
SARS-CoV-2 pathogenesis
Week 9-12: Extended protocol results Users continuing beyond 8 weeks typically see continued, though sometimes slower, progress
Serum albumin and cardiovascular disease: state-of-the-art review
